GlassScriptPhysician profile
Amy M Bruton
NPI 1952365744
$1,970.80
in general payments reported to CMS, 2019-2025
19 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $360 · 2020: $73.04 · 2021: $532 · 2022: $341 · 2023: $535 · 2024: $130.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $665.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $665.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $941.01 | 2019-2023 | Vraylar, Ubrelvy, Orilissa |
| Novo Nordisk INC | $423.64 | 2019-2024 | Wegovy |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $213.15 | 2023-2024 | Caplyta |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $94.93 | 2019-2023 | Xifaxan |
| Therapeuticsmd, INC. | $42.38 | 2019 | |
| Acella Pharmaceuticals, LLC | $33.26 | 2019 | |
| Amag Pharmaceuticals, INC. | $24.33 | 2019 | |
| Lupin INC. | $22.41 | 2019 | |
| Daiichi Sankyo INC. | $20.93 | 2019 | |
| Avion Pharmaceuticals | $20.62 | 2022 | |
| Azurity Pharmaceuticals, INC. | $20.61 | 2023 | Adthyza |
| Phadia US INC. | $17.13 | 2024 | Immunocap |
| Exact Sciences Corporation | $16.59 | 2023 | Cologuard Collection Kit |
| Pfizer INC. | $15.68 | 2023 | |
| Takeda Pharmaceuticals U.S.A., INC. | $15.66 | 2019 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Myovant Sciences INC. | $14.04 | 2022 | |
| Currax Pharmaceuticals LLC | $13.84 | 2023 | Contrave |
| Zyla Life Sciences, INC. | $12.83 | 2020 | |
| Mayne Pharma Commercial LLC | $7.76 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amy Bruton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.